NCT06624189 2026-02-27
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
NYU Langone Health
Enrolling by invitation
Clinical Trials
14 trialsNCT07290764 2025-12-18
Survival Analysis of Surgical Resection Versus Observation in Patients With Initially uHCC Achieving CR After Systemic Therapy
Fujian Provincial Hospital
Enrolling by invitation
NCT06618300 2025-11-17
One&Done
UNC Lineberger Comprehensive Cancer Center
Enrolling by invitation
NCT04539717 2025-10-08
FAST (Focused Abbreviated Screening Technique)-MRI Study
Icahn School of Medicine at Mount Sinai
Enrolling by invitation
NCT06882876 2025-09-19
JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study
Xiangya Hospital of Central South University
Phase 1 Enrolling by invitation
NCT04246970 2025-09-15
PreLiveR-T
Hospital Universitario La Fe
Phase NA Enrolling by invitation
NCT07088081 2025-07-28
Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals
Ain Shams University
Enrolling by invitation
NCT07052448 2025-07-04
The Efficacy of Sequential RT After Triple Therapy for uHCC
Fujian Provincial Hospital
Enrolling by invitation
NCT07042841 2025-06-29
AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer
Beijing Tsinghua Chang Gung Hospital
Enrolling by invitation
NCT06773260 2025-01-22
ELASTO-HCC
Azienda Ospedaliero Universitaria Policlinico Modena
Enrolling by invitation
NCT06647264 2024-10-17
A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery
Nanfang Hospital, Southern Medical University
Enrolling by invitation
NCT06540508 2024-08-06
Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Enrolling by invitation
NCT05429190 2023-11-29
Validation of SMS Protocol for HCC Screening in High-risk Patients
Erasmus Medical Center
Enrolling by invitation
NCT05171335 2022-09-21
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
The Methodist Hospital Research Institute
Phase 2 Enrolling by invitation